Search
Kamada Ltd
KMDAAdd to Watchlist
7.190USD
-0.120-1.64%
Close 06/22, 16:00（ET）Quotes delayed by 15 min
414.76MMarket Cap
20.52P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-22The current earnings forecast score of Kamada Ltd is 8.67, ranking 13 out of 157 in the Pharmaceuticals industry. The average price target is 13.00, with a high of 15.00 and a low of 11.00.
Analyst Rating
Based on
3
analysts
Buy
Current Rating
13.000
Target Price
+77.84%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
175
Total
6
Median
8
Average
Company name
Ratings
Analysts
Kamada Ltd
KMDA
3
Biogen Inc
BIIB
38
Amgen Inc
AMGN
38
Eli Lilly and Co
LLY
35
AbbVie Inc
ABBV
34
Vertex Pharmaceuticals Inc
VRTX
34
1
2
3
...
35
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Kamada Ltd's expected revenue for the next quarter?
Kamada Ltd's expected revenue is 50.66M.
What is Kamada Ltd's price target?
Analysts forecast that Kamada Ltd's price target is USD 13.00, with the highest forecast at USD 15.00 and the lowest forecast at USD 11.00.
How have Kamada LtdKMDA's recent earnings per share performed?
The market expectation was USD 0.07, while Kamada LtdKMDA's earnings per share (EPS) for the previous quarter was USD 0.06. EPS for the next quarter is expected at USD 0.11.
What is the analyst rating for Kamada Ltd?
Based on the ratings of Kamada Ltd's stock from 3 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
